not by any means. Ticked Safety... Hopefully they use the quarterly as another opportunity to provide a timing update on efficacy and aAn update on partnerships or investment interest would be nice...
They will no doubt have major players interested in getting this into the nutraceutical market ASAP - off the back of the safety data. A suitably brokered deal will resolve the short term cap raise pressure that is present.
NTI Price at posting:
4.9¢ Sentiment: Buy Disclosure: Held
